{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:54:26Z","timestamp":1787342066784,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.seizure.2026.02.013","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:11:30Z","timestamp":1770999090000},"page":"102-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy and safety of cenobamate-based combination therapy in drug-resistant epilepsy: Secondary analysis by mechanisms of action of concomitant antiseizure medications"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-5934","authenticated-orcid":false,"given":"Magdalena","family":"Bosak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Podraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"W\u0142och-Kope\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-7275","authenticated-orcid":false,"given":"Andrzej","family":"Rysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3243-4703","authenticated-orcid":false,"given":"Kamil","family":"W\u0119\u017cyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Grabska-Radzikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Sobolewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-6254","authenticated-orcid":false,"given":"Tomasz","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Kurkowska-Jastrz\u0119bska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"S\u0142u\u017cewska-Nied\u017awied\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0792-1077","authenticated-orcid":false,"given":"Katarzyna","family":"Sulima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2922-3510","authenticated-orcid":false,"given":"Lech","family":"Kipi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Kiry\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Stopi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"P\u0142onka-P\u00f3\u0142torak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1844-5599","authenticated-orcid":false,"given":"Justyna","family":"Tabaka-Pradela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0484-4468","authenticated-orcid":false,"given":"Magdalena","family":"Konopko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-1995","authenticated-orcid":false,"given":"Agnieszka","family":"Meller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Chor\u0105\u017cy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Kopytek-Beuzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Dzianott-Pabijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Klimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Nicpo\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Jasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Machowska-Sempruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Fuksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Zawi\u015blak-Fornagiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.seizure.2026.02.013_bib0001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(19)30399-0","article-title":"Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial","volume":"19","author":"Krauss","year":"2020","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2026.02.013_bib0002","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/epi4.12992","article-title":"The cenobamate KORK study-A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add-on lacosamide, perampanel, and brivaracetam","volume":"9","author":"Steinhoff","year":"2024","journal-title":"Epilepsia Open"},{"issue":"7","key":"10.1016\/j.seizure.2026.02.013_bib0003","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1111\/epi.18357","article-title":"Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: interim results after 24-week observational period from the BLESS study","volume":"66","author":"Lattanzi","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.02.013_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.seizure.2025.05.002","article-title":"Efficacy and safety of Cenobamate: a multicenter, retrospective evaluation of real-world clinical practice","volume":"130","author":"Bosak","year":"2025","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2026.02.013_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/epi4.12936","article-title":"Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures","volume":"9","author":"Carre\u00f1o","year":"2024","journal-title":"Epilepsia Open"},{"issue":"4","key":"10.1016\/j.seizure.2026.02.013_bib0006","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/epi4.12959","article-title":"Treatment simplification to optimize cenobamate effectiveness and tolerability: a real-world retrospective study in Spain","volume":"9","author":"Rodr\u00edguez-Uranga","year":"2024","journal-title":"Epilepsia Open"},{"issue":"3","key":"10.1016\/j.seizure.2026.02.013_bib0007","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/epi4.12757","article-title":"Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: outcomes from an expanded Access program","volume":"8","author":"Villanueva","year":"2023","journal-title":"Epilepsia Open"},{"issue":"5","key":"10.1016\/j.seizure.2026.02.013_bib0008","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/epi.18297","article-title":"Real-world use of cenobamate in adults: efficacy and predictors of treatment response","volume":"66","author":"Loushy","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.02.013_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1558614","article-title":"Real-world utilization of Cenobamate as adjunct therapy in office-based neurology: practical tips and insights for titration","volume":"16","author":"House","year":"2025","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2026.02.013_bib0010","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/epi.17549","article-title":"Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: a \"real-world\" retrospective study","volume":"64","author":"Pe\u00f1a-Ceballos","year":"2023","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2026.02.013_bib0011","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/epi.17874","article-title":"Add-on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: a prospective observational study","volume":"65","author":"Novitskaya","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.02.013_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110835","article-title":"Quality of life and synergistic combinations of antiseizure medication in patients treated with cenobamate in early therapy lines for focal-onset seizures","volume":"175","author":"Winter","year":"2026","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2026.02.013_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109156","article-title":"The cenobamate-clobazam interaction- evidence of synergy in addition to pharmacokinetic interaction","volume":"142","author":"Osborn","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2026.02.013_bib0014","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/epi4.12857","article-title":"Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy","volume":"9","author":"Catal\u00e1n-Aguilar","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2026.02.013_bib0015","unstructured":"Ontozry (cenobamate) [Internet]. Amsterdam: European Medicines Agency; 2021 [available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ontozry."},{"key":"10.1016\/j.seizure.2026.02.013_bib0016","unstructured":"XCOPRI (cenobamate tablets) [Internet]. U.S. Food and Drug Administration; 2020 [available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/212839s001lbl.pdf."},{"key":"10.1016\/j.seizure.2026.02.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107242","article-title":"Dose reduction and discontinuation of concomitant antiseizure medications after initiating cenobamate: a retrospective review","volume":"197","author":"Becker","year":"2023","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.seizure.2026.02.013_bib0018","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/epi4.12882","article-title":"WRAPPER study: real-world effectiveness and tolerability of adjunctive perampanel for people with drug-resistant epilepsy in Hong Kong","volume":"9","author":"Chan","year":"2024","journal-title":"Epilepsia Open"},{"issue":"8","key":"10.1016\/j.seizure.2026.02.013_bib0019","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1528-1157.2000.tb00282.x","article-title":"Topiramate in refractory epilepsy: a prospective observational study","volume":"41","author":"Stephen","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.02.013_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.seizure.2022.02.003","article-title":"Efficacy and safety of adjunctive cenobamate: post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications","volume":"96","author":"Brandt","year":"2022","journal-title":"Seizure"},{"issue":"22","key":"10.1016\/j.seizure.2026.02.013_bib0021","doi-asserted-by":"crossref","first-page":"e2311","DOI":"10.1212\/WNL.0000000000009530","article-title":"Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures","volume":"94","author":"Chung","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2026.02.013_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70567","article-title":"Cenobamate in real-word scenario: results on efficacy, side effects, and retention rate in a single center retrospective study","volume":"15","author":"Badr","year":"2025","journal-title":"Brain Behav"},{"key":"10.1016\/j.seizure.2026.02.013_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1239152","article-title":"Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug interactions and neuropsychological impact. What have we learned from real word evidence?","volume":"14","author":"Pietrafusa","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:05:19Z","timestamp":1773169519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"alternative-id":["S1059131126000476"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.02.013","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of cenobamate-based combination therapy in drug-resistant epilepsy: Secondary analysis by mechanisms of action of concomitant antiseizure medications","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}